LeMaitre Vascular, Inc. (NASDAQ:LMAT) Declares Quarterly Dividend of $0.16

LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend on Thursday, October 24th,Zacks Dividends reports. Shareholders of record on Thursday, November 21st will be given a dividend of 0.16 per share by the medical instruments supplier on Thursday, December 5th. This represents a $0.64 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, November 21st.

LeMaitre Vascular has increased its dividend by an average of 13.8% annually over the last three years and has raised its dividend every year for the last 13 years. LeMaitre Vascular has a payout ratio of 29.6% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect LeMaitre Vascular to earn $2.16 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 29.6%.

LeMaitre Vascular Price Performance

Shares of NASDAQ LMAT opened at $103.74 on Wednesday. The firm’s 50-day moving average is $92.45 and its two-hundred day moving average is $86.15. LeMaitre Vascular has a 12-month low of $51.70 and a 12-month high of $106.49. The company has a market capitalization of $2.33 billion, a PE ratio of 56.69, a price-to-earnings-growth ratio of 2.50 and a beta of 0.89.

LeMaitre Vascular (NASDAQ:LMAT) last announced its earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.05. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The firm had revenue of $54.82 million for the quarter, compared to analysts’ expectations of $53.50 million. During the same quarter in the prior year, the firm earned $0.33 EPS. LeMaitre Vascular’s quarterly revenue was up 15.6% on a year-over-year basis. On average, analysts forecast that LeMaitre Vascular will post 1.94 EPS for the current fiscal year.

Insider Buying and Selling

In other LeMaitre Vascular news, Director Bridget A. Ross sold 3,750 shares of LeMaitre Vascular stock in a transaction on Friday, November 15th. The shares were sold at an average price of $101.47, for a total value of $380,512.50. Following the transaction, the director now owns 2,278 shares in the company, valued at $231,148.66. This trade represents a 62.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 10.79% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently commented on LMAT shares. Oppenheimer reiterated an “outperform” rating and set a $93.00 price objective (up previously from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. JMP Securities lifted their price target on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the stock a “market outperform” rating in a report on Tuesday, August 20th. Lake Street Capital began coverage on shares of LeMaitre Vascular in a research note on Friday, August 2nd. They set a “buy” rating and a $105.00 price objective on the stock. Cantor Fitzgerald began coverage on shares of LeMaitre Vascular in a research note on Tuesday, October 15th. They issued a “neutral” rating and a $96.00 target price for the company. Finally, StockNews.com raised LeMaitre Vascular from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.57.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.